Fundraising Fox

Kreos Capital

Venture debt

London · Series A–Late Stage · 43 people tracked

Also known as KREOS CAPITAL GROUP LIMITED · KREOS CAPITAL GROUP V LIMITED · KREOS CAPITAL GROUP VI L.P. · KREOS CAPITAL GROUP VII LP

Fox Verdict
Sign up to see your fit

Investment thesis

Kreos Capital pioneered growth debt financing in Europe and Israel, providing tailored, flexible debt facilities to high-growth technology and healthcare companies. Since 1998 it has committed over EUR 7.0 billion across 830+ transactions to more than 640 companies, deploying more than EUR 800m annually. In technology it backs fintech, enterprise software, cybersecurity, semiconductors, digital marketing and AI companies; in healthcare it funds drug and treatment development, medical products and devices, and healthcare tech. Kreos supports companies through every stage of growth, from entry-level and mid-stage development through to late-stage, pre-IPO/exit, and publicly listed growth funding. Backed by institutional investors, it emphasizes long-term partnership with management teams and equity sponsors.

Source: firm website, verified Aug 3, 2026.

Stage
Series A–Late Stage
HQ
London, GB
Instruments
Debt
Founded
1998
Tracked investments
6

Team · 43 people

from the firm's website & public directories
Aris Constantinides· Managing Director
Marten Vading· Managing Director
Parag Gandesha· Managing Director
Raoul Stein· Managing Director
Ross Ahlgren· Managing Director
Sean Dunne· Managing Director
Sonia Benhamida· Managing Director
Uri Galai· Managing Director
Alex Duffy· Vice President
Chris Church· Executive Director
Damian Polok· Executive Director
David Fitzpatrick· Executive Director
Eugeniu Topala· Vice President
Guillaume Coelho· Vice President
Henry Johnson-King· Vice President
James Cobb· Vice President
Kailey Aliyar· Vice President
Kevin Temke· Executive Director
Maria Garcia-Cerda· Vice President
Mat Pearse· Executive Director
Ragna Portelli· Executive Director
Shane Bourke· Vice President
Todd Spiers· Executive Director
Xixi Richter· Executive Director
Yusuf Shah· Vice President
Giulio Capodimonti· Associate
Guy Arbib· Associate
Jack Broadbent· Analyst
Jocelyn Ng· Analyst
Joshua Pilling· Analyst
Megan Shomo· Analyst
Rahil Patel· Analystin
Ronak Patel· Associate
Ruth Galgut· Assistant
Ryan Jacobs· Analyst
Tomer Dvir· Associate
Yvonne Hughes· Assistant

What they invest in

from 6 of 6 portfolio companies

Biotech ×2E-commerce ×2Healthtech ×2Cloud Computing ×1Consumer ×1Data & Infrastructure ×1Digital Health ×1Direct to Consumer ×1

HQs:United States×2Belgium×1Germany×1Japan×1

Investments · 6 tracked

founders shown can be your intro path
Sequana Medicalsequanamedical.comin𝕏✓ verified

Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.

BiotechHealthtechMedical DevicesGhent, BE

Laminateuselaminate.comin𝕏

Laminate provides physical card design, manufacturing, and fulfillment services for debit and credit card issuers, integrating with existing card issuing infrastructure.

FintechNew York City, US

Khurram Aslam(Founder)in

Marley Spoonmarleyspoon.com𝕏

Marley Spoon is a meal kit delivery service that provides fresh food and recipes to consumers.

Direct to ConsumerE-commerceFoodTechBerlin, DE

Fabian Siegel(Founder & CEO)

Mixtilesmixtiles.com

Mixtiles creates magnetic picture frames and wall art products that can be easily repositioned without damaging walls, featuring museum-quality printing and customizable sizes and materials.

ConsumerE-commerceRetail Tech

RALLYmariadb.comin𝕏

MariaDB develops a relational database system designed to serve as a cost-effective alternative to legacy databases like Oracle for storing and accessing data across mobile, web, and IoT applications.

Cloud ComputingData & InfrastructureEnterprise SoftwareSilicon Valley, US

Vikas Mathur(Chief Product Officer)

TiGenixtakeda.comin

Takeda is a global pharmaceutical company that develops medicines and healthcare solutions across multiple therapeutic areas to improve patient outcomes and expand access to care.

BiotechDigital HealthHealthtechTokyo, JP

Claudia D'Augusta(Executive Officer)June Almenoff(Director)Russell Greig(Director)Eduardo Bravo Fernandez de Araoz(Executive Officer, Director)Jean Stephenne(Director)Marie Paule Richard(Executive Officer)

Frequently asked questions

What stage does Kreos Capital invest at?
Kreos Capital invests at the Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Kreos Capital focus on?
Kreos Capital focuses on AI & Machine Learning, Biotech, Crypto & Web3, Cybersecurity, Enterprise Software, Fintech, Healthtech, Medical Devices, Sector Agnostic, Semiconductors.
Where is Kreos Capital located?
Kreos Capital is headquartered in London, GB.

Media · Podcasts & interviews

featuring the team

"Mai no ha estat tan fàcil engegar projectes" Ross Ahlgren - Kreos Capital

ACCIÓ · Ross Ahlgren

"Les empreses catalanes han de pensar globalment" Ross Ahlgren - Kreos Capital

ACCIÓ · Ross Ahlgren

Co-investors · 4

FELIX CAPITAL

Felix Capital is a venture capital firm investing at the intersection of technology and creativity, focused on the evolution of the human experience at home, at work, and in-between.

$1M – $20M
White Star Capital

White Star Capital is a global multi-stage technology investment platform that partners with founders across multiple markets to help them scale internationally from founding through exit.

$500K – $7M
Octopus Ventures

Octopus Ventures is a founder-focused European venture capital firm that backs mission-driven startups across seven core sectors, investing from idea stage through growth with a focus on pre-seed to Series A.

$130K – $1.3M
Glilot Capital Partners

Glilot Capital Partners is an Israel-based venture capital firm focused on cybersecurity and AI, supporting founders from seed through growth via a multi-program framework (G-Seed, G+, Mach5, G-Club).

$1.5M – $70M

Firms observed investing alongside Kreos Capital, from public investor directories. Shared companies are the overlap with Kreos Capital's recorded portfolio.

Similar investors

Featured in lists